Serviços 
O conteúdo desse portal pode ser acessível em Libras usando o VLibras
Início do conteúdo

Buscar na Fiocruz

Exibindo 25 de 448 resultados encontrados
Opções avançadas
Data de publicação: 15/07/2020 - 11:30
Originally published at Reports in Public Health In 2020, the COVID-19 pandemic has plunged nearly the entire planet into a health and humanitarian crisis, testing the human species in various dimensions. So many doubts raise the following question: is COVID-19 an inevitable phenomenon, given the relationship humans have with the various ecosystems and the other animal and plant species? Or in a simplified approach, is COVID-19 the episodic (...
Notícias
Data de publicação: 14/07/2020 - 12:13
Fiocruz president, Nísia Trindade Lima, is one of the members of the Lancet Covid-19 Commission. Led by American economist Jeffrey Sachs, the commission is an interdisciplinary initiative that includes leaders in health sciences, business, finances, and public policies, to formulate recommendations to overcome the challenges brought by the pandemic. “The Commission was created to help speed up global, equitable, and long...
Notícias
Data de publicação: 14/07/2020 - 11:56
With the goal of better understanding the beginning of the novel coronavirus pandemic in Brazil, researchers of the Oswaldo Cruz Foundation (Fiocruz) have carried out a wide genetic study involving almost a hundred samples from patients from all Brazilian regions, infected by the SARS-CoV-2 virus in the early moments of the pandemic in national territory. The study was led by specialists of the Respiratory Viruses and Measles Laboratory,...
Notícias
Data de publicação: 14/07/2020 - 11:15
Researchers of the Oswaldo Cruz Institute (IOC/Fiocruz) have identified a new strain of the influenza virus in a patient in the city of Ibiporã, in the southern state of Paraná. Analysis have pointed to the presence of the influenza virus A(H1N2)v, which causes infection in pigs. The case was reported to the Ministry of Health, which then notified the World Health Organization (WHO), according to the international health regulation...
Notícias
Data de publicação: 14/07/2020 - 10:29
The international clinical trial HPTN 083 has proven that PrEP (HIV pre-exposure prophylaxis) containing CAB-LA (long-acting injectable Cabotegravir) used every eight weeks yielded efficacy superior to Truvada in the prevention of infection by the virus. “This is an unprecedented success for the field of HIV prevention. PrEP with CAB-LA is a new and powerful strategy that can really make a difference in controlling the HIV/Aids epidemic,...
Notícias
Data de publicação: 13/07/2020 - 17:18
Deaths in the city of Rio de Janeiro have increased by 64% in ths months of April and May 2020, when compared to the average in this same period in the last 3 years. In addition, a detailed analysis of the records shows a disturbing figure: deaths out of hospitals (both in health units, clinics, and other basic healthcare venues and at home) have practically doubled. This may be an indicator that, early in the epidemic, the city’s hospital...
Notícias
Data de publicação: 13/07/2020 - 15:48
Three lineages of the novel coronavirus have been introduced in the state of Amazonas, according to the study run by the Leônidas & Maria Deane Institute (ILMD/Fiocruz Amazônia), which investigated samples from the municipalities of Manacapuru, Autazes, Careiro, and Manaquiri (in the metropolitan region), Santa Isabel do Rio Negro (Rio Negro), Tabatinga, and Santo Antônio do Içá (in the Alto Solimões...
Notícias
Data de publicação: 13/07/2020 - 15:32
United Nations Educational, Scientific and Cultural Organization (UNESCO) has approved the creation of the Oswaldo Cruz Chair of Science, Health and Culture. The welcoming of the proposal presented by Casa de Oswaldo Cruz (COC/Fiocruz) in April 2019 and now approved by the agency is proof of the acknowledgement, by the United Nations agency, of the importance of the area of biomedical and health sciences, and brings with it opportunities for the...
Notícias
Data de publicação: 10/07/2020 - 15:19
Last week (July 1 and 2), the World Health Organization (WHO) hosted the second Global Research and Innovation Forum for Covid-19, with the participation of scientists of the Oswaldo Cruz Foundation (Fiocruz). The Forum, that took place online, had the goal of updating what is currently known about the disease and what are the gaps, where research must invest. The final goal is to speed up the development of knowledge on the subject. The...
Notícias
Data de publicação: 10/07/2020 - 12:50
A study by researchers of the CoVida Network - Science, Information and Solildarity showed that the measures to contain Covid-19 in Brazil have already saved millions of lives, but they are not enough to slow down the spread of the pandemic in Brazil. According to mathematical analysis, even in the states that were stricter in terms of social distancing measures since the beginning of the transmission of the country, this set of actions is still...
Notícias
Data de publicação: 09/07/2020 - 13:41
The Oswaldo Cruz Foundation (Fiocruz) and Convention Secretariat, which serves as the secretariat of both the WHO Framework Convention on Tobacco Control (WHO FCTC) and of the Protocol to Eliminate Illicit Trade in Tobacco Products, entered into a Memorandum of Understanding this Thursday (09 July). The document designates Fiocruz, through its Center for Tobacco and Health Studies (CETAB) of the National School of Public Health Sergio Arouca (...
Notícias
Data de publicação: 30/06/2020 - 17:59
The Oswaldo Cruz Foundation (Fiocruz) will sign an agreement with pharmaceutical company AstraZeneca for the acquisition of batches and transference of technology regarding the Covid-19 vaccine developed by the University of Oxford. The agreement will be the result of the cooperation between the Brazilian government and the pharmaceutic company, announced last Saturday, June 27, by the Ministry of Health. This is a Advance Purchase Agreement...
Notícias
Data de publicação: 29/06/2020 - 16:04
A study led by the Oswaldo Cruz Foundation (Fiocruz) has observed that drugs currently used to treat hepatitis C inhibit the replication of the new coronavirus (SARS-CoV-2) in experiments made with cells. The experiments have identified, in particular, the potential of an antiviral drug, daclastavir, which was able to work against the virus in three different cell lineages under investigation, in addition to reducing the production of...
Notícias
Data de publicação: 29/06/2020 - 15:14
Although respiratory symptoms are the best-known face of Covid-19, post-traumatic stress (PTSD), depression, and anxiety have also been described in patients with the disease. In an article published in Frontiers in Immunology, researchers of the Oswaldo Cruz Institute (IOC/Fiocruz) and of Universidade Federal Fluminense (UFF), in the state of Rio de Janeiro, discuss how the new coronavirus can affect mental health, pointing to neural,...
Notícias
Data de publicação: 26/06/2020 - 18:05
Even in the midst of a pandemic that has affected the everyday life of virtually everyone, Brazilians are still living with the consequences of the last national public health emergency: the zika virus, which has led to the birth of 3,534 babies with congenital zika syndrome (CZS) since 2015. A new strain of the zika virus was recently discovered in Brazil by researchers of the Center for the Integration of Data and Knowledge for Health (Cidacs...
Notícias
Data de publicação: 26/06/2020 - 13:53
The Chagas Consortium of the Oswaldo Cruz Foundation (Fiocruz) has been selected in the first phase of the Unitaid call that aims to eliminate congenital transmisson of Chagas disease in endemic countries in Latin America. The goal of the initiative is to raise awareness on the disease and provide the much-necessary new diagnostic tools and therapeutic strategies, focusing on the reduction of mother-to-baby transmission, considered one of the...
Notícias
Data de publicação: 18/06/2020 - 15:52
Almost R$ 6 million (around US$1,2 million) in tests for Covid-19, personal protective equipment (PPE) and test devices will be donated to state of Amazonas to face the new coronavirus. The material will be transferred by the Oswaldo Cruz Foundation (Fiocruz) Program, United Against Covid-19. The distribution of products will be monitored by Leônidas & Maria Deane Institute (ILMD / Fiocruz Amazônia), explains the researcher...
Notícias
Data de publicação: 18/06/2020 - 15:22
The Institute of Drug Technology (Farmanguinhos/Fiocruz) concluded, in early June, the manufacture of Atazanavir pilot batches, an antiretroviral used to treat thousands of people living with HIV/AIDS. Public production was made possible by a technology transfer agreement from the American laboratory Bristol Myers Squibb to the Fiocruz unit through a Productive Development Partnership (PDP). The drug is used by thousands of people living...
Notícias
Data de publicação: 12/06/2020 - 11:57
The Institute of Technology in Immunobiological Products (Bio-Manguinhos/Fiocruz) is running a Brazilian project to develop a synthetic vaccine against the novel coronavirus (SARS-CoV-2). The studies are now advancing to a pre-clinical phase, in which safety aspects will be assessed in animal models. The synthetic form of the vaccine was chosen for being quicker than traditional methodologies, for its lower production costs, the stability of the...
Notícias
Data de publicação: 10/06/2020 - 13:19
During the new coronavirus epidemic, 36% of the Brazilian elderly who still work have been left without any income, or have experienced significant reduction in their income. Among those without a formal job, this number is even higher: 55%. These are some of the conclusions of ConVid - Behavior Survey, coordinated by Fiocruz, which has been attempting to investigate how the Covid-19 has been affected the lives of Brazilians. More than...
Notícias
Data de publicação: 09/06/2020 - 17:18
During the first weeks of social distancing due to the Covid-19 epidemic, a great part of the Brazilian population reported mood issues. Forty percent felt sad or depressed and 54% felt anxious or nervous frequently. The percentages were even higher among young adults (between 18 and 29 years old): 54 and 70%, respectively. This is one of the many results identified in the first phase of ConVid - Behavior Research, which aimed to...
Notícias
Data de publicação: 04/06/2020 - 13:47
In line with the history and spirit of Dr Oswaldo Cruz, the foundation that carries his name and celebrates its 120th anniversary continues to provide Brazil and the world with innovative and high-quality health services thus fulfilling the bold vision of its creator. In the pantheon of Brazilian national heroes in the field of science, Dr Oswaldo Cruz stands out as the most prominent figure. He was an ambitious man and knew exactly what he...
Notícias
Data de publicação: 03/06/2020 - 22:28
Health-BRC Biological Resource Center for Health and the Brazilian BRC Network Based on the experience with its microbiological collections, Fiocruz had dedicated e  orts to build the Biological Resource Center in Health (CRB-Health), which will consist of collections of pathogenic microorganisms, related mainly to tropical diseases or those with biotechnological potential in the health fi eld, including bacteria, fungi, protozoans, and...
Institucional
Data de publicação: 02/06/2020 - 13:50
They have as their primary function the acquisition, preservation, identification, cataloging and distribution of authenticated microorganisms to support scientific research, epidemiological studies, as well as the development and production of bioproducts for diagnostics, vaccine and drugs, and also acting as specialized services providers. For consulting the services provided by the microbiological collections, including their electronic...
Institucional

Pages

Back to the topBack